Edgewell Personal Care (EPC) Research & Development (2009 - 2026)

Edgewell Personal Care (EPC) has 18 years of Research & Development data on file, last reported at $14.9 million in Q1 2026.

• Research & Development for Q1 2026 came in at $14.9 million, up 11.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.5 million (up 1.39% YoY), and the FY2025 annual result was $57.6 million, down 1.37% from the prior year.
• Research & Development improved to $14.9 million in Q1 2026 per EPC's latest filing, from $13.8 million in the prior quarter.
• Over five years, Research & Development peaked at $16.3 million in Q3 2024 and troughed at $13.3 million in Q4 2023.
• A 5-year average of $14.4 million and a median of $14.2 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2026: Research & Development declined 6.85% in 2022, then advanced 11.19% in 2026.
• A 5-year view of Research & Development shows it stood at $13.4 million in 2022, then retreated by 0.75% to $13.3 million in 2023, then gained by 0.75% to $13.4 million in 2024, then grew by 2.99% to $13.8 million in 2025, then rose by 7.97% to $14.9 million in 2026.
• Business Quant data shows EPC's Research & Development at $14.9 million in Q1 2026, $13.8 million in Q4 2025, and $15.8 million in Q3 2025.